Cannabis Briefs for October 24, 2023

•Arizona saw cannabis sales slow over the summer, according to the state’s Department of Revenue. Arizona’s recreational sales registered $77 million in July, with medical sales at $26 million. That’s down from $85 million in adult-use sales and $28 million in medical sales a month earlier. The drop is even steeper compared with the first quarter of the year, when monthly adult-use sales tallied above $90 million, along with around $30 million in medical sales. Despite the dropoff, the Arizona Mirror projects that the state will equal its 2022 sales total of $1.4 billion for the full year. Amid the decline, multistate operator Cresco Labs sold off its sole Arizona dispensary to an affiliate of Mint Cannabis and exited the state, effective last week.

•New Yorkers have purchased $83 million of legal cannabis so far this year, according to the Empire state’s cannabis administration. The sales figure reflects the state’s slow rollout of dispensaries and competition from the illicit market. To improve access, the state has sped up the licensing process and, last week, announced five new dispensaries—including three in New York City—amid a wider crackdown on unlicensed shops. While the market has been slow to develop, sales are accelerating, with Bloomberg reporting that the last three months saw $51 million in sales, doubling the figure from the three months before that.

•Next month, voters in Ohio will take to the polls and decide whether or not to legalize cannabis sales. According to a new survey 57% of Ohioans plan to vote yes to legalize sales to those over 21 years old on the ballot initiative, Issue 2. The poll, run by Baldwin Wallace University Community Research Institute, shows that solid majorities of Democrats and independents (66.4% and 58.6%) support legalization and that the initiative has a slim majority of support among Republicans, with 50.4% indicating they would vote yes. Support for Issue 2 cuts across demographics with men and women, and urban, suburban, and rural voters all showing majority support.

•Clackamas, Oregon’s Wyld has added a new sour tangerine-flavored hybrid-infused gummy to its line of edibles. The new flavor is the third in the company’s range of Sours, following last year’s Sour Cherry Indica-enhanced and Sour Apple Sativa-enhanced gummy releases, and is the 12th flavored gummy from the company overall. Wyld’s Sour Tangerine will be available this fall in either 5- or 10-mg THC gummies, depending on the state.

Tagged : cannabis

GET YOUR FIRST LOOK AT 2025 ESTIMATES AND 2030 PROJECTIONS FOR THE WINE AND SPIRITS INDUSTRIES. ORDER YOUR 2025 IMPACT DATABANK REPORTS. CLICK HERE.